• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Ishares Iv PLC ISHARES NASDAQ US BIOTEC UCITS USD (ACC) (BTEK)

Sell: £4.502|Buy: £4.518|Change: 0.05 (-1.14%)

Open 

£4.5416

Previous close 

£4.5165

Trade high 

£4.546

Income frequency 

-

Year low 

£4.07496

Year high 

£5.5728

Replication method 

Physical Full

Volume 

1,655

Type 

ETF

UCITS 

Yes

Dividend yield 

–

Ongoing charge 

0.35

ISIN 

IE00BYXG2H39

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Before investing please read:

Key Investor Information Document (KIID)

Share price

Asset allocation

Top 10 holdings

Holdings 25/04/2025% of assets
Vertex Pharmaceuticals Inc9.13
Amgen Inc8.08
Gilead Sciences Inc8.00
Regeneron Pharmaceuticals Inc7.16
AstraZeneca PLC ADR4.48
Alnylam Pharmaceuticals Inc3.60
argenx SE ADR2.18
Biogen Inc1.92
Summit Therapeutics Inc Ordinary Shares1.91
Sanofi SA ADR1.66

Performance 31/03/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Fund- 1.14
Category-
More...

Investment objective

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.

Asset class

ETF

Morningstar ratingTM

Morningstar sustainability ratingTM

Morningstar Medalist RatingTM

  Morningstar analyst document

  Morningstar report document

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.